These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24686571)

  • 1. Multiple factors are involved in the dysarthria associated with Parkinson's disease: a review with implications for clinical practice and research.
    Sapir S
    J Speech Lang Hear Res; 2014 Aug; 57(4):1330-43. PubMed ID: 24686571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parametric quantitative acoustic analysis of conversation produced by speakers with dysarthria and healthy speakers.
    Rosen KM; Kent RD; Delaney AL; Duffy JR
    J Speech Lang Hear Res; 2006 Apr; 49(2):395-411. PubMed ID: 16671852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Speech motor programming in hypokinetic and ataxic dysarthria.
    Spencer KA; Rogers MA
    Brain Lang; 2005 Sep; 94(3):347-66. PubMed ID: 16098382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dysarthria across Parkinson's disease progression. Natural history of its components: dysphonia, dysprosody and dysarthria].
    Pinto S; Ghio A; Teston B; Viallet F
    Rev Neurol (Paris); 2010 Oct; 166(10):800-10. PubMed ID: 20800250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intonation contrast in Cantonese speakers with hypokinetic dysarthria associated with Parkinson's disease.
    Ma JK; Whitehill TL; So SY
    J Speech Lang Hear Res; 2010 Aug; 53(4):836-49. PubMed ID: 20029050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Game-Based Augmented Visual Feedback for Enlarging Speech Movements in Parkinson's Disease.
    Yunusova Y; Kearney E; Kulkarni M; Haworth B; Baljko M; Faloutsos P
    J Speech Lang Hear Res; 2017 Jun; 60(6S):1818-1825. PubMed ID: 28655041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of speaking rate on articulatory hypokinesia in parkinsonian dysarthria.
    Caligiuri MP
    Brain Lang; 1989 Apr; 36(3):493-502. PubMed ID: 2706450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating interactional competencies in Parkinson's disease: the potential benefits of a conversation analytic approach.
    Griffiths S; Barnes R; Britten N; Wilkinson R
    Int J Lang Commun Disord; 2011; 46(5):497-509. PubMed ID: 21899668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of intensive speech rate and intonation therapy on intelligibility in Parkinson's disease.
    Martens H; Van Nuffelen G; Dekens T; Hernández-Díaz Huici M; Kairuz Hernández-Díaz HA; De Letter M; De Bodt M
    J Commun Disord; 2015; 58():91-105. PubMed ID: 26519934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parkinsonian dysarthria].
    Gentil M; Pollak P; Perret J
    Rev Neurol (Paris); 1995 Feb; 151(2):105-12. PubMed ID: 7676137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Speech motor stability in IPD: effects of rate and loudness manipulations.
    Kleinow J; Smith A; Ramig LO
    J Speech Lang Hear Res; 2001 Oct; 44(5):1041-51. PubMed ID: 11708525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Speech Versus Speaking: The Experiences of People With Parkinson's Disease and Implications for Intervention.
    Yorkston K; Baylor C; Britton D
    Am J Speech Lang Pathol; 2017 Jun; 26(2S):561-568. PubMed ID: 28654939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Speech therapy for the dysarthria of Parkinson's disease].
    Ozsancak C; Auzou P
    Rev Neurol (Paris); 2005 Sep; 161(8-9):857-61. PubMed ID: 16244572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive-perceptual examination of remediation approaches to hypokinetic dysarthria.
    McAuliffe MJ; Kerr SE; Gibson EM; Anderson T; LaShell PJ
    J Speech Lang Hear Res; 2014 Aug; 57(4):1268-83. PubMed ID: 24687031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Speech Prosody Across Stimulus Types for Individuals with Parkinson's Disease.
    K-Y Ma J; Schneider CB; Hoffmann R; Storch A
    J Parkinsons Dis; 2015; 5(2):291-9. PubMed ID: 25697957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subthalamic nucleus stimulation and dysarthria in Parkinson's disease: a PET study.
    Pinto S; Thobois S; Costes N; Le Bars D; Benabid AL; Broussolle E; Pollak P; Gentil M
    Brain; 2004 Mar; 127(Pt 3):602-15. PubMed ID: 14736753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility and validity of patient-rated assessment of speech, swallowing, and saliva control in Parkinson's disease.
    Kalf JG; Borm GF; de Swart BJ; Bloem BR; Zwarts MJ; Munneke M
    Arch Phys Med Rehabil; 2011 Jul; 92(7):1152-8. PubMed ID: 21704797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left-sided hemihypomimia in Parkinson's disease.
    Crosiers D; Maréchal E; van Ael Y; Cras P
    Acta Neurol Belg; 2011 Sep; 111(3):225-7. PubMed ID: 22141289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The place of perceptual analysis of dysarthria in the differential diagnosis of corticobasal degeneration and Parkinson's disease.
    Ozsancak C; Auzou P; Jan M; Defebvre L; Derambure P; Destee A
    J Neurol; 2006 Jan; 253(1):92-7. PubMed ID: 16096817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential causes and consequences of overlap in talk between speakers with Parkinson's disease and their familiar conversation partners.
    Griffiths S; Barnes R; Britten N; Wilkinson R
    Semin Speech Lang; 2012 Feb; 33(1):27-43. PubMed ID: 22362322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.